Data from Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
Authors:
- F. Michael YakesFYF. Michael Yakes
- Jason ChenJCJason Chen
- Jenny TanJTJenny Tan
- Kyoko YamaguchiKYKyoko Yamaguchi
- Yongchang ShiYSYongchang Shi
- Peiwen YuPYPeiwen Yu
- Fawn QianFQFawn Qian
- Felix ChuFCFelix Chu
- Frauke BentzienFBFrauke Bentzien
- Belinda CancillaBCBelinda Cancilla
- Jessica OrfJOJessica Orf
- Andrew YouAYAndrew You
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)